Session Information
-
WCLC 2021
2021 World Conference on Lung Cancer
Presentation Date(s):- September 8 - 14, 2021
- Total Presentations: 1107
All times listed are in Mountain Time MDT (UTC-6:00)
PL - Plenary
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
FP - Featured Posters
P - Posters
WS - Workshops
IS - Industry Symposium
MTE - Meet the Expert
BEDG - Brain Exchange Discussion Groups
September 8 Wed
Sep 8 Thursday
September 9 Thu
Sep 9 Friday
September 10 Fri
Sep 10 Saturday
September 11 Sat
Sep 11 Sunday
September 12 Sun
Sep 12 Monday
September 13 Mon
Sep 13 Tuesday
September 14 Tue
Sep 14
-
+
PDT - Product Showcase
- 00:00 - 23:59
- 9/08/2021
- Location: Product Theater
- Type: Product Showcase
- Track: N.A.
-
+
PDT.01 - Product Showcase by Astrazeneca - A Discussion on Treatment Options for Resectable NSCLC and Stage III Unresectable NSCLC
00:00 - 00:00
- Abstract
No abstract available for this presentation
-
+
PDT.02 - Product Showcase by Bayer - Precision Oncology: The Clinical Role of TRK Fusions as the Primary Oncogenic Driver in TRK Fusion Cancer: Program for Lung Specialists
00:00 - 00:00
- Abstract
No abstract available for this presentation
-
+
PDT.03 - Product Showcase by Blueprint Medicines - Changing the Standard of Care for Patients with RET Fusion+ Metastatic NSCLC
00:00 - 00:00
- Abstract
No abstract available for this presentation
-
+
PDT.04 - Product Showcase by Boehringer Ingelheim - Thinking Beyond KRAS G12C Inhibition in NSCLC
00:00 - 00:00
- Abstract
No abstract available for this presentation
-
+
PDT.05 - Product Showcase by Boehringer Ingelheim - Pushing Checkpoint Inhibition Beyond PD-1
00:00 - 00:00
- Abstract
No abstract available for this presentation
-
+
PDT.06 - Product Showcase by Boehringer Ingelheim - What Can We Learn About the Evolving Squamous NSCLC Treatment Landscape? An Expert Discussion on Emerging Real-World Evidence
00:00 - 00:00
- Abstract
No abstract available for this presentation
-
+
PDT.07 - Product Showcase by G1 Therapeutics - Cosela™: A Novel Myeloprotection Therapy
00:00 - 00:00
- Abstract
No abstract available for this presentation
-
+
PDT.08 - Product Showcase by Genentech - Emerging Perspectives in Multidisciplinary Treatment of Early-Stage and Locally Advanced Non-Small Cell Lung Cancer
00:00 - 00:00
- Abstract
No abstract available for this presentation
-
+
PDT.09 - Product Showcase by Janssen Biotech - EGFR Exon 20 Insertion Mutations – Emerging Implications for the Management & Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC)
00:00 - 00:00
- Abstract
No abstract available for this presentation
-
+
PDT.10 - Product Showcase by Natera - Applications of ctDNA Testing in Lung Cancer: Learning from Other Tumor Types
00:00 - 00:00
- Abstract
No abstract available for this presentation
-
+
PDT.11 - Product Showcase by Oncocyte - DetermaRx – Treatment Stratification in Early-Stage NSCLC
00:00 - 00:00
- Abstract
No abstract available for this presentation
-
+
PDT.12 - Product Showcase by Pfizer - Overview of Efficacy and Safety Data For a First-Line Treatment Option for ALK+ Metastatic NSCLC
00:00 - 00:00
- Abstract
No abstract available for this presentation
-
+
PDT.13 - Product Showcase by Pfizer - Multidisciplinary Insights Into Biomarker Testing in Metastatic Non-Small Cell Lung Cancer (NSCLC)
00:00 - 00:00
- Abstract
No abstract available for this presentation
-
+
PDT.14 - Product Showcase by Takeda - ALUNBRIG® (brigatinib): A Treatment Option for Patients With Anaplastic Lymphoma Kinase (ALK)–Positive Metastatic Non-Small Cell Lung Cancer (NSCLC)
00:00 - 00:00
- Abstract
No abstract available for this presentation
-
+
PDT.15 - Product Showcase by Thermo Fisher - Next-Generation Sequencing (NGS) in 2021: Impact on Routine Clinical Practice
00:00 - 00:00
- Abstract
No abstract available for this presentation
-
+
MTE01 - Meet the Expert - Targeted Therapies and/or Immunotherapy
- 05:45 - 06:45
- 9/08/2021
- Location: IASLC Booth via Industry Hub and Exhibit Hall
- Not for CME Credit
- Type: Meet the Expert Sessions
- Track: N.A.
- Moderators:Edgardo S Santos
-
+
MTE01.01 - Targeted Therapies and/or Immunotherapy
05:45 - 06:45 | Presenter: Luis E. Raez
- Abstract
No abstract available for this presentation
-
+
MTE02 - Meet the Expert - Screening, Incidental Nodules, and Adjuvant Therapy for Early-Stage Lung Cancer
- 05:45 - 06:45
- 9/08/2021
- Location: IASLC Booth via Industry Hub and Exhibit Hall
- Not for CME Credit
- Type: Meet the Expert Sessions
- Track: N.A.
- Moderators:Raymond Uyiosa Osarogiagbon
-
+
MTE02.01 - Screening, Incidental Nodules, and Adjuvant Therapy for Early-Stage Lung Cancer
05:45 - 06:45 | Presenter: Paula A. Ugalde Figueroa
- Abstract
No abstract available for this presentation
-
+
PL01 - Opening Plenary: Access and Disparities (Japanese, Mandarin, Spanish Translation Available)
- 07:00 - 08:00
- 9/08/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Plenary
- Track: N.A.
- Moderators:Lucia Zatarain Barron, Tetsuya Mitsudomi
-
+
PL01.01 - Introduction and IASLC Award Presentations
07:00 - 07:30
- Abstract
No abstract available for this presentation
-
+
PL01.02 - Disparities in Lung Cancer Care Across the Population
07:30 - 07:40 | Presenter: Raymond Uyiosa Osarogiagbon
- Abstract
Loading... -
+
PL01.03 - Disparities in Lung Cancer Care: The Global Burden
07:40 - 07:50 | Presenter: Alex Adjei
- Abstract
No abstract available for this presentation
-
+
PL01.04 - Live Discussion with Speakers
07:50 - 08:00
- Abstract
No abstract available for this presentation
-
+
MA01 - Multimodality Management of Advanced Lung Cancer
- 08:15 - 09:15
- 9/08/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Mini Oral
- Track: Multimodality of Advanced Lung Cancer
-
+
MA01.01 - The Role of Surgery for M1a Non-Small-Cell Lung Cancer with Contralateral Lung Involvement
08:15 - 08:20 | Presenter: Arvind Kumar
- Abstract
Loading... -
+
MA01.02 - Surgical Complexity of Pulmonary Resections Performed for Oligometastatic Non-Small Cell Lung Cancer
08:20 - 08:25 | Presenter: Mara Antonoff
- Abstract
Loading... -
+
MA01.03 - PREC Multicentre Restrospective Study: A Preoperative Risk Classification for Synchronous Oligometastatic Non-Small Cell Lung Cancer
08:25 - 08:30 | Presenter: Luca Bertolaccini
- Abstract
Loading... -
+
MA01.04 - Discussant
08:30 - 08:45 | Presenter: Linda W Martin
- Abstract
No abstract available for this presentation
-
+
MA01.05 - Sintilimab, SBRT and GM-CSF for Advanced NSCLC: Safety Run-in Results of a Prospective, Multicenter, Phase II Trial
08:45 - 08:50 | Presenter: Jianjiao Ni
- Abstract
Loading... -
+
MA01.06 - Effects of the Immunotherapy Era on Maintenance Outcomes in Advanced Nonsquamous NSCLC: Subgroup Analysis of ECOG 5508
08:50 - 08:55 | Presenter: Bharathi Muthusamy
- Abstract
Loading... -
+
MA01.07 - Prognostic Value of STK11 & KRAS Mutations and irAE Incidence in Response to Immunotherapy in Hispanics: A Multicenter Analysis
08:55 - 09:00 | Presenter: Fahmin Basher
- Abstract
Loading... -
+
MA01.08 - Discussant
09:00 - 09:15 | Presenter: Karen Reckamp
- Abstract
No abstract available for this presentation
-
+
OA01 - The Impact of COVID-19 on Patients with Lung Cancer
- 08:15 - 09:15
- 9/08/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Oral
- Track: Management of Lung Cancer in the Era of COVID-19
- Moderators:Enriqueta Felip
-
+
OA01.01 - Analysis of Lung Cancer Patients Receiving SARS-CoV-2 Vaccines Revealed a Minority Subset With Poor Antibody Responses Relative to Controls
08:15 - 08:25 | Presenter: Jorge E Gomez
- Abstract
Loading... -
+
OA01.02 - Impact of COVID-19 Outbreak on Lung Cancer Diagnosis and Continuum of Care: Data From an Italian Multicenter Study
08:25 - 08:35 | Presenter: Luca Cantini
- Abstract
Loading... -
+
OA01.03 - Immune Checkpoint Inhibitor Dose Adaptation During the COVID-19 Pandemic in Non-Small Cell Lung Cancer– a Single-Center Experience
08:35 - 08:45 | Presenter: Lucie Brigitte Marie Hijmering-Kappelle
- Abstract
Loading... -
+
OA01.04 - Discussant
08:45 - 08:55 | Presenter: Suresh Ramalingam
- Abstract
No abstract available for this presentation
-
+
OA01.05 - Live Discussion with Speakers
08:55 - 09:05
- Abstract
No abstract available for this presentation
-
+
OA02 - Contemporary Approaches to Supportive Care
- 08:15 - 09:15
- 9/08/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Oral
- Track: Palliative and Supportive Care
- Moderators:Grace Yang
-
+
OA02.01 - Assessment of Patient-Reported Outcomes in Lung cancer Patients Treated with Thoracic Radiation
08:15 - 08:25 | Presenter: Li Yang
- Abstract
Loading... -
+
OA02.02 - Development of Machine Learning Model to Estimate Overall Survival in Patients with Advanced NSCLC and ECOG-PS > 1
08:25 - 08:35 | Presenter: Mateus Trinconi Cunha
- Abstract
Loading... -
+
OA02.03 - Medical Assistance in Dying (MAiD) in Patients With Lung Cancer
08:35 - 08:45 | Presenter: Sara Moore
- Abstract
Loading... -
+
OA02.04 - Phase II Trial of Antiemetic Oral Granisetron Plus Dexamethasone for Nausea and Vomiting Caused by Crizotinib in ALK or ROS1 Fusion-Positive NSCLC
08:45 - 08:55 | Presenter: Kenji Kawasumi
- Abstract
Loading... -
+
OA02.05 - Discussant
08:55 - 09:05 | Presenter: Monica Malec
- Abstract
No abstract available for this presentation
-
+
OA02.06 - Live Discussion with Speakers
09:05 - 09:15
- Abstract
No abstract available for this presentation
-
+
MA02 - RET and Novel Combinations of Osimertinib
- 09:30 - 10:30
- 9/08/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Mini Oral
- Track: Novel Therapeutics and Targeted Therapies
-
+
MA02.01 - Efficacy and Safety of Selpercatinib in Chinese Patients With RET Fusion-Positive Non-Small Cell Lung Cancer: A Phase 2 Trial
09:30 - 09:35 | Presenter: Shun Lu
- Abstract
Loading... -
+
MA02.02 - Efficacy and Safety of Pralsetinib in Chinese Patients with Advanced RET Fusion+ Non-Small Cell Lung Cancer
09:35 - 09:40 | Presenter: Qing Zhou
- Abstract
Loading... -
+
MA02.03 - MET-Driven Acquired Resistance (AR) in Fusion-Positive Non-Small Cell Lung Cancer (NSCLC)
09:40 - 09:45 | Presenter: Sai-Hong I. Ou
- Abstract
Loading... -
+
MA02.04 - Discussant
09:45 - 10:00 | Presenter: Shengxiang (Harry) Ren
- Abstract
No abstract available for this presentation
-
+
MA02.05 - A Phase I Study of Afatinib in Combination With Osimertinib in Patients After Failure of Prior Osimertinib
10:00 - 10:05 | Presenter: Satoru Miura
- Abstract
Loading... -
+
MA02.06 - Phase 1b Study of Pelcitoclax (APG-1252) in Combination With Osimertinib in Patients With EGFR TKI-Resistant NSCLC
10:05 - 10:10 | Presenter: Li Zhang
- Abstract
Loading... -
+
MA02.07 - T-DM1 and Osimertinib (TRAEMOS) To Target HER2 Bypass Track Resistance in EGFRm+ NSCLC: Interim Analysis of a Phase II Trial
10:10 - 10:15 | Presenter: Merel Jebbink
- Abstract
Loading... -
+
MA02.08 - Discussant
10:15 - 10:30 | Presenter: Adrian G. Sacher
- Abstract
No abstract available for this presentation
-
+
OA03 - Novel Approaches to Cessation in Cancer Care
- 09:30 - 10:30
- 9/08/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Oral
- Track: Risk Reduction and Tobacco Control
- Moderators:Matthew Allen Steliga
-
+
OA03.01 - Implementation of an Opt-Out Smoking Cessation Service for Oncology Patients
09:30 - 09:40 | Presenter: Michael Cummings
- Abstract
Loading... -
+
OA03.02 - Tobacco Cessation Among Patients Undergoing Lung Cancer Screening: Success with Repetition
09:40 - 09:50 | Presenter: April Plank
- Abstract
Loading... -
+
OA03.03 - Patient Factors Associated With Engagement of an Academic Institution Tobacco Cessation Referral Program
09:50 - 10:00 | Presenter: Sarah Westergaard
- Abstract
Loading... -
+
OA03.04 - Discussant
10:00 - 10:10 | Presenter: Lawson Eng
- Abstract
No abstract available for this presentation
-
+
OA03.05 - Live Discussion with Speakers
10:10 - 10:30
- Abstract
No abstract available for this presentation
-
+
OA04 - Improving Thoracic Oncology Patient Outcomes
- 09:30 - 10:30
- 9/08/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Oral
- Track: Nursing and Allied Health Professionals
- Moderators:Zoe Merchant
-
+
OA04.01 - Preconditioning with Move For Surgery Shortens Hospital Stay after Lung Cancer Surgery
09:30 - 09:40 | Presenter: Yogita S. Patel
- Abstract
Loading... -
+
OA04.02 - Diaphragm and Phrenic Nerve Preservation During Lung-Sparing Surgery for Malignant Pleural Mesothelioma: The Impact on Patient Outcomes
09:40 - 09:50 | Presenter: Melissa Jane Culligan
- Abstract
Loading... -
+
OA04.03 - Feasibility of Prospective Dietetic Assessment and Intervention of Patients Receiving Chemo-Radiotherapy for Lung Cancer
09:50 - 10:00 | Presenter: Catherine Samuelson
- Abstract
Loading... -
+
OA04.04 - Discussant
10:00 - 10:10 | Presenter: Carolyn Peddle-McIntyre
- Abstract
No abstract available for this presentation
-
+
OA04.05 - Live Discussion with Speakers
10:10 - 10:30
- Abstract
No abstract available for this presentation